Clinical Predictive Factors for the Efficacy of Everolimus in Patients With Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer: A Multicenter Retrospective Cohort Study in Japan.
Yuichiro KikawaTakeshi KotakeYukiko KajiwaraKazuki HashimotoHiroyasu YamashiroShoichiro OhtaniShintaro TakaoMasakazu ToiPublished in: Breast cancer : basic and clinical research (2019)
Low hormone sensitivity and ⩾3 liver metastases were important prognostic factors for the efficacy of EVE. EVE may be less effective in patients with AMBC with these factors, and as such, chemotherapy should be administered instead.